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ABSTRACT 
 
Cell attachment to the extracellular matrix (ECM) engages 
integrin signaling into the cell, but part of the signaling 
response also stem from cell spreading (3). To analyze specific 
integrin signaling-mediated responses independent of cell 
spreading, we developed a method engaging integrin signaling 
by use of an immobilized anti-integrin monoclonal antibody 
(mab) directed against the fibronectin (FN) receptor integrin 
α5β1. ECV 304 cells were plated onto FN or immobilized mab 
JBS5 (anti-integrin α5β1) or onto poly-L-lysin (P-L-L), which 
mediates integrin-independent attachment. Cells attached and 
spread on FN, while cells on JBS5 or P-L-L attached but did 
not spread. Importantly, plating onto FN or mab JBS5 gave rise 
to identical integrin-induced responses, including a down-
regulation of the cyclin-dependent kinase (Cdk2) inhibitors 
p21
CIP1 and p27
KIP1, while attachment to P-L-L did not. We 
conclude that engagement of the FN-receptor integrin α5β1 
induces integrin signaling regulating the Cdk2-inhibitors 
independent of cell spreading and present a method for how 
integrin signaling can be analyzed separate from the effects of 
cell spreading. 
 
INTRODUCTION 
 
Integrins constitute a family of transmembrane cell surface 
receptors composed of one α and one β subunit. Today, 18 α 
and 8 β subunits have been identified with different 
combinations comprising 24 different integrins (9). Binding of 
integrins to their ligand extracellular matrix (ECM) protein 
generates various signals into the cell that control a variety of 
cellular functions, including cell adhesion, spreading, motility, 
differentiation, proliferation and survival (5).  
 
In most experimental studies, integrin ligation to the ECM is 
analyzed by allowing cell attachment to an ECM protein pre-
coated solid surface. However, this kind of setting hardly 
elucidates each individual integrin function. This is because 
cell attachment to one ECM protein typically engages several 
different integrins. For example, integrin α5β1 is a major 
receptor for fibronectin (FN), while integrins α4β1 and αvβ3 
also interact with FN (7). In addition, the effects of cell 
adhesion to an ECM protein may be mediated by other 
transmembrane receptors such as syndecans, which can bind to 
FN and generate a cellular response (10). Therefore, 
establishment of specific integrin engagement is an important 
supplement for the investigation of a specific integrin function. 
Furthermore, integrin signaling is mostly accompanied with 
cell spreading, which also contributes to intracellular signals 
(3). Therefore, there is a need for a simple method that can 
analyze the effects that are caused by specific integrin ligation 
per se independent of cell spreading. 
 
Clustering of integrins can be achieved not only by ECM 
proteins, but also by specific immobilized anti-integrin 
antibodies. This notion was firstly used to determine integrin 
expression on cells by allowing cell attachment to immobilized 
anti-integrin monoclonal antibodies (mabs) (6). Furthermore, 
immobilized anti-integrin antibodies can be used as integrin-
agonists for analysis of integrin signaling (8,11,12). Here, we 
developed a method using an immobilized anti-integrin mab to 
assess integrin α5β1-mediated cellular responses independent 
of cell spreading. We used this method to examine events that 
may be involved in integrin control of cell proliferation. 
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MATERIALS AND METHODS 
 
Cells 
 
ECV 304/T24 human bladder carcinoma cells (2) (American 
Type Culture Collection, Rockville, MD) were cultured in 
Dulbecco’s Modified Eagles’s medium (DMEM) (Life 
Technologies) containing 5% fetal calf serum (FCS) and 50 
µg/ml gentamicin at 37°C in 5% CO2. Prior to the experiments, 
cells were grown to confluence and starved overnight in serum-
free medium in order to silence any sustained effects from 
growth factor signaling. This was performed to examine 
exclusively the signaling stemming from integrins without any 
influence from growth factors. After washing and 
trypsinization for 2 min, trypsin was neutralized with soybean 
trypsin inhibitor (1 mg/ml). Cells were then washed and 
suspended in DMEM containing 2% BSA at 37°C for 45 min 
as previously described to silence any active anchorage-
dependent signaling (4). 
 
Immobilization of anti-integrin monoclonal 
antibodies 
 
Cell culture suspension dish (Corning) was used in this study 
since this kind of dish contributes to the prevention of 
unspecific cell attachment and allows antibody binding to its 
surface. The suspension dishes were first coated with 25 µg/ml 
affiniPure F(ab’)2  fragment goat anti-mouse IgG (H+L) 
(Jackson Labs) in PBS at 37°C for 2 h, followed by blocking 
with 1% heat-denatured BSA for 1 h at 37°C to inhibit non-
specific binding in the subsequent steps. Then, 10 µg/ml of 
mouse monoclonal antibodies anti-β1 integrin (P4C10, 
Chemicon Int., Temecula, CA), anti-α5β1 integrin (JBS5, 
Chemicon Int.) or anti-αvβ3 integrin (LM609, Chemicon Int) 
were allowed to bind to the immobilized anti-mouse antibody 
at 4°C overnight. For comparison, suspension culture dishes 
were coated with 10 µg/ml fibronectin (FN, cell binding 
fragment, Upstate Biotechology, Lake Placid, NY), or 100 
µg/ml poly-L-lysine (P-L-L, Sigma) in PBS overnight at 4°C, 
and then blocked with 1% heat-denatured BSA in PBS (pH 
7.4) for 1 h at 37°C. 
 
Cell attachment to immobilized anti-integrin 
monoclonal antibodies 
 
Serum-starved ECV 304 cells were suspended in DMEM plain 
medium that was deprived of phenol red to get rid of potential 
effects of serum factors as well as the hormone-like effects that 
might be caused by phenol red. Then, cells were plated onto 
the pre-coated dishes and incubated for various times at 37°C 
in 5% CO2 as described previously (1). The same population of 
cells was also plated onto fibronectin (FN) or poly-L-lysin (p-
L-L) pre-coated dishes. Cells were photographed using a 
converted microscope with a 20× objective using a digital 
camera and images were processed to a composition using 
Micrografx Windows Draw 6.0 software (Micrografx Inc). 
Finally, the cells were harvested and rinsed in cold PBS and 
frozen at -20°C.  
Western blotting  
Cells were lysed in a PBS-TDS buffer (PBS with 1% Triton X-
100, 0.5% sodium deoxycholate, 0.1% SDS, 1 mM EDTA 1 
mM PMSF, 1× complete inhibitor cocktail (Boehringer 
Mannheim)). Protein concentrations in lysates were measured 
using a BCA protein quantification kit (Pierce, Rockford, IL) 
using BSA as a standard. 15 µg of total proteins were separated 
by 12% SDS-PAGE gel and transferred to an Immobilon 
polyvinylidene fluoride (PVDF) membrane (Millipore, 
Bedford, MA). After blocking with 10% dry milk in TBS-T (20 
mM Tris-HCl, 0.5 M NaCl, 0.2% Tween-100), membranes 
were incubated with primary antibodies anti-p21
CIP1 pab (Ab-5, 
Oncogene), anti-p27
KIP1 mab (F-8, Santa Cruz) or anti-actin 
mab (JLA20, Developmental Studies Hybridoma Bank 
University of Lowa) for 1 h at room temperature. Following 
washes and 30 min incubation with HRP-conjugated goat anti-
rabbit or goat anti-mouse secondary antibodies (Jackson Labs), 
membranes were visualized by an enhanced ECL Renaissance 
kit (NEN
Tm Life Science Products) and then exposed to 
Hyperfilm ECL (Amersham) for various times to get bands 
within the linear range of sensitivity. The levels of actin were 
analyzed as a control for constant loading. 
RESULTS AND DISCUSSION 
 
 
Fig. 1: Cell morphology was observed upon attachment 
onto immobilized anti-integrin mabs. Photographs (20× 
objective) show representative morphology of ECV 304 cells 
after attachment onto dishes pre-coated with fibronectin (FN), 
anti-integrin mabs JBS5 (anti-α5β1), P4C10 (anti-β1) or 
LM609 (anti-αvβ3) and poly-L-lysin (p-L-L) for 30 min. 
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Immobilized anti-integrin monoclonal antibodies (mabs) can 
act as agonistic integrin-ligating proteins and thereby promote 
formation of integrin clusters, which are critical for the 
activation of integrin-mediated responses. In this study, we 
developed the use of an immobilized anti-α5β1 integrin mab to 
assess  α5β1–activated cellular functions independent of cell 
spreading. To this end, anti-integrin mab JBS5 (anti-α5β1) was 
immobilized onto suspension cell culture dishes, using the 
ECM protein fibronectin (FN) or poly-L-lysin (P-L-L) or 
immobilized anti-integrin β1 mab P4C10, or anti-integrin αvβ3 
mab LM 609 as comparison. Human bladder carcinoma ECV 
304 cells were plated onto these substrates for various times. 
Firstly, the morphology of ECV 304 cells was observed after 
30 min of attachment (Fig. 1). We found that ECV 304 cells 
adhered and spread to the same degree on FN or immobilized 
mabs P4C10 or LM 609 within 30 min. This indicates that 
plating onto immobilized mabs P4C10 or LM 609 mimics the 
attachment and spreading occurring when cells attach onto FN. 
In contrast, cells plated onto immobilized mab JBS5 attached 
but did not spread. Similarly, cells plated onto P-L-L, which 
mediates integrin-independent attachment, also attached but 
did not spread. Although ligation to immobilized JBS5 and P-
L-L both mediated attachment but not spreading, the effects of 
α5β1-ligation were very different from that of attachment to P-
L-L. When examining regulation of the cyclin-dependent 
kinase (Cdk2) inhibitors p21
CIP1 and p27
KIP1, we found that the 
Cdk2-inhibitors were strongly down-regulated upon cell 
attachment to FN or any of the immobilized mabs within 30 
min, while cell attachment to P-L-L did not affect the Cdk2 
inhibitor levels (Fig. 2). 
 
 
Fig. 2: Immobilized anti-integrin mabs rapidly down-
regulate protein levels of the Cdk2- inhibitors p21
CIP1 and 
p27
KIP1. ECV 304 cells were plated onto FN, anti-integrin 
mabs P4C10 (anti-β1), LM609 (anti-αvβ3) or JBS5 (anti-
α5β1) or onto poly-L-lysine (P-L-L) that mediates integrin-
independent cell attachment. The protein levels of the Cdk2-
inhibitors p21
CIP1 and p27
KIP1 were determined by Western 
blotting. Actin levels were analyzed as a loading control. 
 
This demonstrates that engagement of integrin-α5β1 by 
immobilized JBS5 without cell spreading gives the same 
cellular response as attachment to FN or to immobilized P4C10 
or LM609, suggesting that this response is caused by integrin 
signaling independent of cell spreading. This is supported by 
our finding that plating cells onto immobilized anti-α5β1 mab 
JBS5 could activate a variety of signals, including FAK, 
ERK1/2 and the small GTPase Cdc42, in a similar manner after 
plating onto FN, while attachment to P-L-L did not (Bao and 
Strömblad, unpublished results). These results indicate that the 
engagement of the FN receptor integrin α5β1 by immobilized 
JBS5 is sufficient to generate various signaling responses 
independent of cell spreading. Naturally, the use of JBS5 is not 
suitable for functional analysis of integrin-induced signaling 
involved in cell spreading. In addition, although this method 
can be adapted to analyze signaling also from other integrins 
than α5β1, it can not be predicted which anti-integrin mab will 
support signaling and/or cell spreading. Therefore, each anti-
integrin mab has to be tested out individually for functionality 
in this assay. For example, the functional blocking capacity of 
an anti-integrin antibody in suspension is not potential 
necessarily predictive for its capacity to support cell spreading 
when immobilized, since the anti-integrin αvβ5 mab P1F6 is 
functionally blocking in suspension but does not support cell 
spreading when immobilized (11).  
 
In conclusion, we have developed a method to study integrin 
α5β1 signaling independent of potential contributions from cell 
spreading. We have successfully used this method to examine 
the effects of integrin signaling on regulating key cell cycle 
components that might be involved in anchorage-dependent 
growth control. 
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PROTOCOLS 
 
Protocol 1: Preparation of cells 
 
Reagents: 
 
Cell culture medium. Dudlbecco’s Modified Eagles’s medium (DMEM #41966-029, Life Technologies) contains 5% fetal calf 
serum (FCS #14-603F, Bio Whittaker) and 50 µg/ml gentamicin (#15710-049, Life Technologies). 
 
Phosphate buffer saline (PBS, # 18912-014, Life Technologies). One PBS tablet is dissolved in 500 ml distilled H2O at pH 7.4 and 
sterilized.  
  
Trypsin. (# 35400-027, Life Technologies) 
 
Soybean trypsin inhibitor (#17+75-029, GIBCO). Soybean is dissolved in PBS and used at a final concentration of 1 mg/ml. Store 
at -20°C  
 
Blocking medium. DMEM containing 2% bovine serum albumin (BSA, # A2153, Sigma). 
 
Protocol:   
 
1.  Culture human bladder carcinoma ECV 304/T24 cells in cell culture medium until 100 % confluence. 
2.  Starve cells overnight in serum-free DMEM medium. 
3.  Wash cells twice with PBS and then trypsinize cells for 2 min at 37°C followed by neutralization with soybean trypsin 
inhibitor at a final concentration of 1 mg/ml. 
4.  Wash cells twice with DMEM plain medium, suspend cells in blocking medium and then carefully agitate the cells at 37°C for 
45 min. 
 
Protocol 2: Immobilization of anti-integrin monoclonal antibodies 
 
Reagents: 
 
Blocking buffer (PBS/heat denatured BSA). This buffer is prepared by boiling PBS containing 1% BSA (pH 7.4) at 100°C until the 
solution becomes opaque (approximate 14 min) and then chilled on ice. 
 
Fibronectin (FN, 110 KD α cell-binding fragment, #08-103, Upstate Biotechology). FN is dissolved in PBS (pH 7.4) and used at a 
final concentration of 10 µg/ml. 
 
Poly-L-lysine (P-L-L, # P9404, Sigma). P-L-L is dissolved in PBS (pH 7.4) and used at a final concentration of 100 µg/ml.  
 
AffiniPure F(ab´)2 fragment goat anti-mouse Ig G (H+L) (#115-006-003, Jackson Labs)   
Monoclonal antibodies (mAbs): 
 
Table 1: 
Specificity Clone  Product  #  Isotype  Source 
Anti-β1 integrin  P4C10 MAB1987  IgG1  Chemicon  Int. 
Anti-α5β1 integrin  JBS5 MAB1969  IgG1 Chemicon  Int. 
Anti-αvβ3 integrin  LM609 MAB1976Z  IgG1  Chemicon  Int. 
 
Suspension cell culture dishes. (#430591, Corning) 
 
Protocol: 
 
1.  Coat suspension culture dishes with 25 µg/ml of goat anti-mouse IgG (H+L) at 37°C for 2 h and block the dishes with 
blocking buffer at 37°C for 1 h. 
2.  Wash the dishes twice with PBS and then coat dishes with 10 µg/ml of mouse anti-integrin monoclonal antibodies anti-α5β1 
(JBS5) in PBS which will bind to immobilized anti-mouse antibodies at 4°C overnight. Simultaneously, coat suspension Bao and Strömblad    86 
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culture dishes with 10 µg/ml of FN and 100 µg/ml of P-L-L, respectively, in PBS at 4°C overnight, followed by coating with 
blocking buffer at 37°C for 1h. 
3.  Wash dishes twice with PBS for coming use, do not leave dishes to dry.  
Protocol 3: Cell attachment onto immobilized anti-integrin monoclonal antibodies 
 
Reagents:  
 
DMEM medium deprived of phenol red. (#21063-029, LifeTechnologies) 
 
Protocol: 
 
1.  Suspend serum-starved ECV 304 cells with DMEM medium deprived of phenol red. 
2.  Plate cells onto the pre-coated dishes and then incubate at 37°C in 5% CO2 for the desired time appropriate for the signaling 
response to be analyzed. 
3.  Photograph cells using converted microscopy at 20× objective with a digital camera and process images to a composition 
using a software Micrografx Windows Draw 6.0 (Micrografx Inc). 
4.  Harvest cells by washing twice with cold PBS and freeze at -20°C.  
 
Protocol 4: Detection of the protein levels of Cdk2 inhibitors p21
CIP1 and p27
KIP1 
 
Reagents: 
Lysis buffer (PBS-TDS). The buffer PBS-TDS (1X) contains 0.5% of sodium deoxycholate 0.1% of SDS, 0.1% of Triton X-100, 
1mM EDTA, 1mM PMSF and 1X stock complete inhibitor cocktail (#697498, Boehringer Mannheim) in PBS. 
BCA protein quantification kit. Mix Reagent A (#CA46141, Pierce) and reagent B (#BJ45506, Pierce) at a ratio 50 to 1 and then 
add 50 µl of the mixture to each well of the plates (PS Microplatte 96 Well, # 655101, Greiner Lab). After incubation with 5 µl of 
total lysates in the Reagent A and B mixture for 30-60 min at 37°C, measure protein concentrations by spectrophotometer at dual 
wavelengths (450 and 650 nm), using known BSA concentrations as standard.     
 
Acrylamide/Bis-acrylamide 30%. (Ratio 29:1, #SL-9218, Scotlab) 
Sodium dodecyl sulfate. (SDS, #161-0302, Bio-Rad) 
Immobilon polyvinylidene fluoride (PVDF) membrane. (#IPVH00010, Millipore)  
 
Gel running buffer (10X stock). Dissolve 30g Trisbase, 144g glycine and 10g SDS in 1 liter distilled H2O.  
 
Transfer buffer. This buffer contains 25 mM Tris base, 0.2 M glycine, 20% methanol (pH 8.5). 
 
Loading buffer (1X). This buffer contains 50 mM Tris-HCl (pH6.8), 100mM dithiothreitol 2% (w/v) SDS, 10% glycerol, 0.01% 
(w/v) bromophenol blue.    
 
Washing buffer (1XTBS-T). This buffer contains 20 mM Tris-base (#T1503, Sigma), 500  mM sodium chloride (#1.06404, Merck) 
and 0.2% Tween-100 (#8.22184.0500, Merck).  
 
Blocking buffer. TBS-T containing 10% dry milk. 
 
Antibody dilution buffer. TBS-T containing 0.5% dry milk.  
 
Primary antibodies. 
 
Table 2: 
Specificity Clone  Product  #  Isotype  Source 
Anti-p21
CIP1 pAb                 PC55  IgG  Oncogene 
Anti-p27
KIP1mAb F-8  SC1641  IgG1  Santa  Cruz 
Anti-Actin  mAb               JLA20  Supernatant  IgM  Developmental Studies 
Hybridoma Bank Bao and Strömblad    87 
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HRP-conjugated goat anti-mouse IgG. (#115-116-146, Jackson Labs) 
HRP-conjugated goat anti-mouse IgM. (#115-035-020, Jackson Labs) 
HRP-conjugated goat anti-rabbit IgG. (#111-035-003, Jackson Labs) 
 
ECL Renaissance kit. (# NEL-104, NEN
Tm Life Science Products) 
 
Hyperfilm
TM ECL
TM. (RPN3114K, Amersham) 
 
 
Protocol: 
1.  Lyse cells with PBS-TDS buffer on ice for 10 min and vortex twice in the meanwhile. 
2.  Spin lysates at 13000 rpm (Biofuge Fresco) at 4°C for 15 min and save the supernatant lysate. 
3.  Measure total protein concentration in lysates with a BCA protein quantification kit, using BSA as a standard.  
4.  Add loading buffer to each sample, heat to 99°C for 5 min, cool on ice and spin at 13000 rpm for 10 seconds. 
5. Run  15  µg of total proteins by a 12% SDS-PAGE gel in gel running buffer with Mini-Protein 3 Electrophoresis system (#165-
3301, Bio-Rad) and transfer to a PVDF membrane for 120 min at constant voltage (80V) in transfer buffer. 
6.  Block the membrane with blocking buffer overnight at room temperature. 
7.  Incubate membrane with primary antibodies anti-p21
CIP1 pAb (1: 1000 dilution), anti-p27
KIP1 mAb (1:200 dilution) or anti-
actin mAb (1:1000 dilution) in antibody dilution buffer for 1h at room temperature.  
8.  Rinse membrane twice with TBS-T within 1 h and then incubate membrane with secondary antibody HRP-conjugated goat 
anti-rabbit or goat anti-mouse in antibody dilution buffer for 30 min at room temperature. 
9.  Rinse membrane twice with TBS-T within 30 min.  
10.  Incubate membrane with enhanced ECL kit for 1 min, drain membrane, and then expose to Hyperfilm ECL for various times 
to get exposures within the linear range of sensitivity. 
 